Torrey Growth & Income Advisors

Position in IBRX — ImmunityBio, Inc.

CIK 2087822 DEL MAR, CA

Position in IBRX

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$1,040,619

+$615,318 QoQ

Shares Held

118,860

+114.4% QoQ

Ownership

0.011%

of shares outstanding

% of Portfolio

0.37%

of 13F equity value

Holder Rank

#105

of 404 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Torrey Growth & Income Advisors holds $6,964,754 across 5 Biotechnology names. IBRX ranks #4 (14.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	4,710	$2,339,598
2	VCEL	Vericel Corp	38,308	$1,704,322
3	NTLA	Intellia Therapeutics, Inc.	70,669	$1,195,719
4	IBRX	ImmunityBio, Inc. This page	118,860	$1,040,619
5	CADL	Candel Therapeutics, Inc.	66,456	$684,496

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,040,619	118,860	+114.4%	Shares	Sole	2026-07-27
2026-03-31	$425,301	55,450	—	Shares	Sole	2026-04-21
No filing history on record for this holder in this stock.